SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-23-007905
Filing Date
2023-03-14
Accepted
2023-03-14 17:13:00
Documents
76
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K virx-20221231.htm   iXBRL 10-K 3731437
2 EX-23.1 virx-ex23_1.htm EX-23 12104
3 EX-31.1 virx-ex31_1.htm EX-31 21340
4 EX-31.2 virx-ex31_2.htm EX-31 21004
5 EX-32.1 virx-ex32_1.htm EX-32 17604
6 GRAPHIC img98420049_0.jpg GRAPHIC 31096
7 GRAPHIC img98420049_1.jpg GRAPHIC 26096
8 GRAPHIC img98420049_2.jpg GRAPHIC 18340
9 GRAPHIC img98420049_3.jpg GRAPHIC 19306
10 GRAPHIC img98420049_4.jpg GRAPHIC 35635
11 GRAPHIC img98420049_5.jpg GRAPHIC 20804
  Complete submission text file 0000950170-23-007905.txt   12673469

Data Files

Seq Description Document Type Size
12 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT virx-20221231.xsd EX-101.SCH 70555
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT virx-20221231_pre.xml EX-101.PRE 448164
14 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT virx-20221231_def.xml EX-101.DEF 298296
15 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT virx-20221231_cal.xml EX-101.CAL 54870
16 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT virx-20221231_lab.xml EX-101.LAB 599164
70 EXTRACTED XBRL INSTANCE DOCUMENT virx-20221231_htm.xml XML 2261271
Mailing Address 2533 S COAST HWY 101 SUITE 210 CARDIFF CA 92007
Business Address 2533 S COAST HWY 101 SUITE 210 CARDIFF CA 92007 858-400-8470
Viracta Therapeutics, Inc. (Filer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-51531 | Film No.: 23731973
SIC: 2834 Pharmaceutical Preparations